Conceptio › Archive › NCBI PubMed Central
NCBI PubMed Centralopen access

Novel Skp1 inhibitor has potent preclinical efficacy against castration-resistant prostate cancer.

Li X et al. · ncbi_pmc
NCBI PubMed Central · Papers · License: Open Access
Open Source ↗Direct PDF ↓
computer-science-education
computer science education

Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.

Record · ID 30825 · SHA-256 7a2da2f07043d688
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.